C WorldWide Group’s Tetraphase Pharmaceuticals TTPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
– Sell
-23,076
Closed -$2.14M – 127
2016
Q1
$2.14M Sell
23,076
-8,200
-26% -$819K 0.04% 69
2015
Q4
$6.27M Hold
31,276
– – 0.11% 51
2015
Q3
$4.67M Buy
31,276
+6,676
+27% +$4.9M 0.08% 54
2015
Q2
$23.3M Buy
24,600
+300
+1% +$245K 0.33% 29
2015
Q1
$17.8M Buy
24,300
+20,378
+520% +$15.3M 0.25% 33
2014
Q4
$3.12M Sell
3,922
-1,078
-22% -$580K 0.05% 60
2014
Q3
$2M Buy
+5,000
New +$1.34M 0.03% 78

Other funds holding TTPH

C WorldWide Group's TTPH Position: Q2 2016 in Review

C WorldWide Group sold out of Tetraphase Pharmaceuticals (TTPH) in Q2 2016, closing a stake of 23,076 shares — an estimated $2.14M sold.

C WorldWide Group first reported a position in TTPH in Q3 2014 and held it in 7 quarters. The position peaked at $23.3M in Q2 2015. 91 funds tracked by Wall St. Rank hold TTPH as of Q2 2016.

  • C WorldWide Group reported no remaining Tetraphase Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • C WorldWide Group sold 23,076 Tetraphase Pharmaceuticals shares in Q2 2016, an estimated $2.14M.
  • C WorldWide Group first reported a position in Tetraphase Pharmaceuticals in Q3 2014 and held it in 7 quarters.
  • C WorldWide Group's Tetraphase Pharmaceuticals position peaked at $23.3M in Q2 2015.
  • 91 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals as of Q2 2016.

Based on C WorldWide Group's 13F filing for Q2 2016, filed 29 Jul 2016.